Abstract
Cdk10 is a Cdc2-related kinase that may play a role in regulating the G2/M phase of the cell cycle. However little is known about the proteins that interact with this putative kinase and contribute to its function in the cell. We report in this study that Cdk10 interacts with the N-terminus of the Ets2 transcription factor, which contains the highly conserved Pointed domain and transactivation domain. The Pointed domain has been implicated in protein–protein interactions and we find that Ets2 requires an intact Pointed domain to bind Cdk10. The Pointed domain of Ets1 is highly similar to Ets2, however Cdk10 does not recognize Ets1 in a two-hybrid assay thereby demonstrating significant binding specificity on the part of Cdk10. We find that Cdk10 binds full length Ets2 in vitro and in vivo and inhibits Ets2 transactivation in mammalian cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Basuyaux JP, Ferreira E, Stehelin D, Buttice G . 1997 J. Biol. Chem. 272: 26188–26195
Brambilla R, Draetta G . 1994 Oncogene 9: 3037–3041
Breeden L, Nasmyth K . 1987 Cell 48: 389–397
Carroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG . 1996 Proc. Natl. Acad. Sci. USA 93: 14845–14850
Chumakov AM, Chen DL, Chumakova EA, Koeffler HP . 1993 J. Virol. 67: 2421–2425
Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G, Sun Y, Colburn N, Calabretta B, Giordano A . 1994 Cancer Res. 54: 5556–5560
Dohrmann PR, Voth WP, Stillman DJ . 1996 Mol. Cell. Biol. 16: 1746–1758
Golemis EA, Serebriiskii J, Gyuris J, Brent R . 1997 Current Protocols in Molecular Biology John Wiley & Sons: NY pp 20.1.1–20.1.35
Grana X, Claudio PP, De Luca A, Sang N, Giordano A . 1994 Oncogene 9: 2097–2103
Graves BJ, Petersen JM . 1998 Adv. Cancer Res. 75: 1–55
Gyuris J, Golemis E, Chertkov H, Brent R . 1993 Cell 75: 791–803
Herskowitz I . 1987 Nature 329: 219–222
Jayaraman G, Srinivas R, Duggan C, Ferreira E, Swaminathan S, Somasundaram K, Williams J, Hauser C, Kurkinen M, Dhar R, Weitzman S, Buttice G, Thimmapaya B . 1999 J. Biol. Chem. 274: 17342–17352
Jousset C, Carron C, Boureux A, Quang CT, Oury C, Dusanter-Fourt I, Charon M, Levin J, Bernard O, Ghysdael J . 1997 EMBO J. 16: 69–82
Li S, MacLachlan TK, De Luca A, Claudio PP, Condorelli G, Giordano A . 1995 Cancer Res. 55: 3992–3995
Liu AY, Corey E, Vessella RL, Lange PH, True LD, Huang GM, Nelson PS, Hood L . 1997 Prostate 30: 145–153
MacLachlan TK, Sang N, De Luca A, Puri PL, Levrero M, Giordano A . 1998 J. Cell. Biochem. 71: 467–478
MacLachlan TK, Sang N, Giordano A . 1995 Crit. Rev. Eukaryot. Gene. Expr. 5: 127–156
Morgan DO . 1997 Annu. Rev. Cell. Dev. Biol. 13: 261–291
Puri PL, Wu Z, Zhang P, Wood LD, Bhakta KS, Han J, Feramisco JR, Karin M, Wang JY . 2000 Genes. Dev. 14: 574–584
Schneikert J, Lutz Y, Wasylyk B . 1992 Oncogene 7: 249–256
Sementchenko VI, Schweinfest CW, Papas TS, Watson DK . 1998 Oncogene 17: 2883–2888
Seth A, Watson DK, Blair DG, Papas TS . 1989 Proc. Natl. Acad. Sci. USA 86: 7833–7837
Sherman F . 1991 Methods Enzymol. 194: 3–21
Simpson S, Woodworth CD, DiPaolo JA . 1997 Oncogene 14: 2149–2157
Slupsky CM, Gentile LN, Donaldson LW, Mackereth CD, Seidel JJ, Graves BJ, McIntosh LP . 1998 Proc. Natl. Acad. Sci. USA 95: 12129–12134
van den Heuvel S, Harlow E . 1993 Science 262: 2050–2054
Watson DK, McWilliams MJ, Lapis P, Lautenberger JA, Schweinfest CW, Papas TS . 1988 Proc. Natl. Acad. Sci. USA 85: 7862–7866
Watson MA, Buckholz R, Weiner MP . 1996 Biotechniques 21: 255–259
Wen SC, Ku DH, De Luca A, Claudio PP, Giordano A, Calabretta B . 1995 Exp. Cell. Res. 217: 8–14
Yang BS, Hauser CA, Henkel G, Colman MS, Van Beveren C, Stacey KJ, Hume DA, Maki RA, Ostrowski MC . 1996 Mol. Cell. Biol. 16: 538–547
Acknowledgements
We are grateful to Alexi Chumakov and Dennis Watson for plasmids and Erica Golemis for two-hybrid reagents and advice. We wish to thank Barbara Graves and the members of the Giordano lab for helpful discussions. We especially thank Peter Stiegler and Robert Mecklenburg for their support and encouragement. M Kasten was supported by NCI training grant 5 T32 CA 09137. This work was supported by a grant from the National Institutes of Health awarded to A Giordano.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kasten, M., Giordano, A. Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity. Oncogene 20, 1832–1838 (2001). https://doi.org/10.1038/sj.onc.1204295
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204295
Keywords
This article is cited by
-
Discovery of sparse, reliable omic biomarkers with Stabl
Nature Biotechnology (2024)
-
Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer
Oncogene (2022)
-
Transcription factor Ets-2 regulates the expression of key lymphotropic factors
Molecular Biology Reports (2020)
-
Association of Cyclin Dependent Kinase 10 and Transcription Factor 2 during Human Corneal Epithelial Wound Healing in vitro model
Scientific Reports (2019)
-
Association of human height-related genetic variants with familial short stature in Han Chinese in Taiwan
Scientific Reports (2017)